Table 1 Comparison of characteristics between two groups

From: Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers

 

10 μg HB vaccine group

20 μg HB vaccine group

P

Mothers

N = 150

N = 199

 

Age (years)

23(22–28)

28(26–30)

<0.001

HBV DNA (log10 IU/mL)

8.17(6.82–8.42)

8.15(7.85–8.34)

0.892

Infants

N = 150

N = 202

 

Gender

  

0.409

 Male

78(52.0)

114(56.4)

 

 Female

72(48.0)

88(43.6)

 

Birth weight (kg)

3.4(3.1–3.5)

3.4(3.1–3.6)

0.485

Delivery mode

  

0.001

 Cesarean

90(60.0)

154(76.2)

 

 Vaginal

60(40.0)

48(23.8)

 

Feeding mode

  

0.839

 Non-breastfeeding

104(69.3)

138(68.3)

 

 Breast or mixed feeding

46(30.7)

64(31.7)

 

HBIG dose

   

 100 IU

65(43.3)

202(100)

<0.001

 200 IU

85(56.7)

0

 

Booster immunization

  

0.929

 Yes

55(36.7)

75(37.1)

 

 No

95(63.3)

127(62.9)